AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10766581
Drug: Azithromycin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (1200 mg weekly)
Trial: 8676932
Drug: Both drugs
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both drugs (Rifabutin and Azithromycin)
Trial: 28186425
Drug: Oral tramadol/propofol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tramadol/propofol fast (GOF)
Trial: 28186425
Drug: Oral tramadol/propofol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tramadol/propofol slow (GOS)
Trial: 22009806
Drug: Preoperative antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative antibiotic prophylaxis administered before TUL
Trial: 22009806
Drug: TUL without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TUL without antibiotic prophylaxis
Trial: 19571807
Drug: CYP2C9 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYP2C9 and VKORC1 genotype-guided dosing
Trial: 19571807
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard dosing without genotype guidance)
Trial: 1926232
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (acetylsalicylic acid and dipyridamole)
Trial: 6861867
Drug: Sotalol 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 100 mg intravenously
Trial: 6861867
Drug: Sotalol 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 400 mg orally
Trial: 30879998
Drug: 0.37 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.37 μg of Alt a 1
Trial: 30879998
Drug: 0.2 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 μg of Alt a 1
Trial: 24780066
Drug: Low-dose glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose glucose (0.1 g/kg/h for 1 h followed by 0.05 g/kg/h for 1 h)
Trial: 24780066
Drug: Low-dose glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose glucose (LG group)
Trial: 23062390
Drug: Preseasonal grass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preseasonal grass pollen immunotherapy
Trial: 19453867
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health education program (4-month duration)
Trial: 15898864
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy for insomnia during discontinuation
Trial: 15898864
Drug: No cognitive-behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No cognitive-behavior therapy for insomnia during discontinuation
Trial: 9819068
Drug: Cortisol 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol 40 mg/d
Trial: 9819068
Drug: Cortisol 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol 160 mg/d
Trial: 8836591
Drug: 5-hydroxy-L-tryptophan (L-5-HTP)
RxNorm normalized name: 5-hydroxy-L-tryptophan
DrugBank: Oxitriptan (DB02959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-hydroxy-L-tryptophan (L-5-HTP) plus carbidopa
Trial: 3308389
Drug: L-5-HTP
RxNorm normalized name: L-5-HTP
DrugBank: Oxitriptan (DB02959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-5-HTP
Trial: 2694344
Drug: Furazolidone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furazolidone (5 mg/kg/day for 5 days)
Trial: 3054035
Drug: Ampicillin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin (100 mg/kg/day for 5 days)
Trial: 22013799
Drug: Blank control
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blank control group (no treatment)
Trial: 26681020
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg clopidogrel (test preparation)
Trial: 26681020
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg clopidogrel (reference preparation)
Trial: 26681020
Drug: Relative bioavailability
RxNorm normalized name: (2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relative bioavailability of the test preparation
Trial: 23059649
Drug: Baseline serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline serum 25D <50.0 nmol/L in 50% of subjects
Trial: 22136021
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Fugui Gutong capsule (3 times a day, 4 capsules each time) and 0.3 g ibuprofen (once a day)
Trial: 19891770
Drug: Low-dose adenosine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose adenosine infusion
Trial: 9456291
Drug: Nifedipine capsules
RxNorm normalized name: Nifedipine Capsules
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine capsules (10 mg, two administrations 6 hours apart)
Trial: 9456291
Drug: Nifedipine-retard (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine-retard (20 mg tablets, single administration)
Trial: 2576717
Drug: Vecuronium 'high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 'high dose' group (250 micrograms.kg‐1)
Trial: 2576717
Drug: Succinylcholine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine group (1 mg.kg‐1)
Trial: 6794587
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg flurazepam
Trial: 27633643
Drug: Enhanced Usual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced Usual Care (EUC): a manualised consultation with a child and adolescent psychiatrist and individualised treatment plan
Trial: 27633643
Drug: Group-based Acceptance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based Acceptance and Commitment Therapy (ACT) plus Enhanced Usual Care (EUC)
Trial: 20831989
Drug: Batroxobin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Batroxobin (5 IU through intravenous drip once every alternate day for a total of six doses)
Trial: 16309036
Drug: Ketoconazol 400
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazol 400 mg + Clindamycin 100 mg for 6 days (K/C6D)
Trial: 16309036
Drug: Ketoconazol 800
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazol 800 mg + Clindamycin 100 mg for 3 days + placebo for 3 days (K/C3D)
Trial: 11868797
Drug: Valsartan/hydrochlorothiazide combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan/hydrochlorothiazide combination (80 mg valsartan o.d. for 4 weeks, then fixed combination if needed)
Trial: 11868797
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 mg o.d. for 4 weeks, then increased to 10 mg if needed)
Trial: 9728901
Drug: Combined contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined contraceptive pill (250 microg levonorgestrel plus 30 microg ethinyl estradiol) administered intravaginally, one tablet per week for 8 weeks
Trial: 9728901
Drug: Conjugated estrogen
RxNorm normalized name: Conjugated estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogen cream (0.625 mg conjugated equine estrogens) administered intravaginally, 1 gm at bedtime, three times in the first week, twice in the second week, and then once a week for the next 6 weeks
Trial: 7639971
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose didanosine (200 mg for bodyweight < 60 kg; 134 mg for bodyweight ≥ 60 kg)
Trial: 7639971
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose didanosine (750 mg for bodyweight ≥ 60 kg; 500 mg for bodyweight < 60 kg)
Trial: 7639971
Drug: Both low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both low and high dose didanosine
Trial: 28053896
Drug: Champignon extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Champignon extract 50 mg/day
Trial: 28053896
Drug: Champignon extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Champignon extract 500 mg/day
Trial: 28053896
Drug: Champignon extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Champignon extract 1000 mg/day
Trial: 25565656
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of intravenous hydrocortisone 2 hours prior to surgery
Trial: 23493410
Drug: Systematic CRT
RxNorm normalized name: Integrase Inhibitors, antiinfectives for systematic use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systematic CRT optimization (at implant, at 3 and 6 months)
Trial: 15918057
Drug: Valsartan (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (160 mg/day)
Trial: 17182977
Drug: HOE‐140 (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE‐140 (18 μg/kg/h i.v. for 6 h)
Trial: 11489570
Drug: Timolol maleate
RxNorm normalized name: Timolol Maleate
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol maleate 0.5% twice a day
Trial: 11489570
Drug: Timolol maleate
RxNorm normalized name: Timolol Maleate
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol maleate 0.5% twice a day and dorzolamide 2% 3 times a day
Trial: 28784054
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion according to low-dose standard protocol
Trial: 28784054
Drug: Sublingual Misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual Misoprostol 25 μg every 4 h
Trial: 23043888
Drug: riluzole treatment
RxNorm normalized name: Riluzole
DrugBank: Riluzole (DB00740)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: riluzole treatment for 8 weeks
Trial: 18234290
Drug: Enoxaparin (0.67
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (0.67 mg/kg)
Trial: 16827700
Drug: sulphadoxine/pyrimethamine (SP),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulphadoxine/pyrimethamine (SP), administered up to four times during pregnancy
Trial: 8451010
Drug: Cabergoline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (0.5 mg to 2.5 mg, taken once a day for 8 weeks)
Trial: 3953366
Drug: Nicardipine hydrochloride
RxNorm normalized name: Nicardipine Hydrochloride
DrugBank: Nicardipine (DB00622)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicardipine hydrochloride (0.5 mg)
Trial: 29887287
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg oral CBD
Trial: 29887287
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral THC
Trial: 22508151
Drug: 57 μg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 57 μg/kg/day r-hGH
Trial: 22508151
Drug: 35 μg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 μg/kg/day r-hGH
Trial: 19996196
Drug: High-dose pirfenidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose pirfenidone (1,800 mg/day)
Trial: 19996196
Drug: Low-dose pirfenidone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose pirfenidone (1,200 mg/day)
Trial: 11898025
Drug: Somatropin (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatropin (0.15 mg/kg/day divided into two equal doses via intramuscular injection)
Trial: 7772081
Drug: Colestipol tablets
RxNorm normalized name: colestipol Oral Tablet
DrugBank: Colestipol (DB00375)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colestipol tablets 4 g/day
Trial: 7772081
Drug: Colestipol tablets
RxNorm normalized name: colestipol Oral Tablet
DrugBank: Colestipol (DB00375)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colestipol tablets 16 g/day
Trial: 7772081
Drug: Colestipol granules
RxNorm normalized name: COLESTIPOL GRANULES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol granules 4 g/day
Trial: 7772081
Drug: Colestipol granules
RxNorm normalized name: COLESTIPOL GRANULES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol granules 16 g/day
Trial: 7438772
Drug: Metoprolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100 mg twice daily, increased to a maximum of 400 mg)
Trial: 7438772
Drug: Metoprolol (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (same total dosage as twice-daily regimen, administered once daily)
Trial: 2563096
Drug: Aspirin 75
RxNorm normalized name: aspirin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 75 mg once daily
Trial: 22789884
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg once daily
Trial: 17876251
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Oxycodone and Ibuprofen
Trial: 8497169
Drug: enalapril (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril (10-40 mg/d)
Trial: 8497169
Drug: atenolol (25-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol (25-100 mg/d)
Trial: 8497169
Drug: verapamil-retard (120-240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil-retard (120-240 mg/d)
Trial: 8497169
Drug: alphametildopa (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alphametildopa (250 mg/8h to 3 g/d)
Trial: 3580510
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine formulations (10 mg single dose)
Trial: 25480874
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (5-FU/LV or capecitabine)
Trial: 23323721
Drug: Medication dispensing
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Medication dispensing device
Trial: 19799779
Drug: Community occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community occupational therapy programme including 10 sessions occupational therapy at home
Trial: 19799779
Drug: Community occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community occupational therapy consultation based on information material of the Alzheimer Society
Trial: 19799779
Drug: Community occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community occupational therapy programme
Trial: 9780942
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment approach
Trial: 9780942
Drug: Counseling combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Counseling combined with different occlusal treatments
Trial: 8091317
Drug: ZD2138 (350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZD2138 (350 mg)
Trial: 1571381
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g of cefodizime
Trial: 3377456
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of cefodizime
Trial: 3377456
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of cefotaxime
Trial: 31754065
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg orally 24 hours prior to procedure and misoprostol 400 μg buccally 2 hours before procedure
Trial: 15156528
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA (fish oil supplements) - 1.8 g of EPA and 1.2 g of DHA daily for 2 years
Trial: 9386869
Drug: TOR240 (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TOR240 (240 mg daily)
Trial: 9386869
Drug: TAM40 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAM40 (40 mg daily)
Trial: 8197648
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of papaverine, phentolamine, and PGE1
Trial: 3046409
Drug: Metered Dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered Dose Inhaler (MDI) Bricanyl
Trial: 26282650
Drug: Obinutuzumab (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Obinutuzumab (1,000 mg)
Trial: 25098075
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of movie-based simulation training and traditional verbal training (group A, n = 30)
Trial: 21150850
Drug: Remifentanil (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (continuous infusion 0.25 mcg/kg · min)
Trial: 21150850
Drug: Fentanyl (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (bolus dose 2.0 mcg/kg)
Trial: 9068334
Drug: Intra-articular tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular tenoxicam 20 mg
Trial: 10442960
Drug: Intravenous tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tenoxicam
Trial: 7786822
Drug: CPT-11 administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT-11 administered as a 30-min i.v. infusion according to 3 different schedules: daily for 3 consecutive days every 3 weeks, weekly for 3 weeks, and once every 3 weeks.
Trial: 12230222
Drug: Itraconazole (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (50-100 mg d(-1))
Trial: 12230222
Drug: Ketoconazole (200-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (200-400 mg d(-1))
Trial: 12230222
Drug: Sulfadiazine (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadiazine (100-150 mg kg d(-1) up to 6 g d(-1))
Trial: 30503111
Drug: D&C plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D&C plus ACP gel
Trial: 24395298
Drug: Hydroxyzine 25
RxNorm normalized name: hydroxyzine 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine 25 mg + Alcohol 0.8 g/kg (HYD + A)
Trial: 24395298
Drug: Bilastine 80
RxNorm normalized name: bilastine
DrugBank: Bilastine (DB11591)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Bilastine 80 mg + Alcohol 0.8 g/kg (B80 + A)
Trial: 24395298
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 mg + Alcohol 0.8 g/kg (CET + A)
Trial: 24395298
Drug: Bilastine 20
RxNorm normalized name: Bilastine 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilastine 20 mg + Alcohol 0.8 g/kg (B20 + A)
Trial: 24395298
Drug: Alcohol 0.8
RxNorm normalized name: isopropyl alcohol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.8 g/kg alone (ALC)
Trial: 12806595
Drug: Enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril maleate (40 mg/day) for six months
Trial: 1739794
Drug: Single high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high dose of vitamin A supplementation
Trial: 6340411
Drug: Sucrose high
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose high sodium solution (90 mEq/l)
Trial: 6340411
Drug: Sucrose low
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose low sodium solution (58 mEq/l)
Trial: 30612511
Drug: Group reminiscence
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group reminiscence therapy with internet-based videos for 60 minutes once a week for 3 months
Trial: 20615267
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg Fe (ferrous sulphate) daily
Trial: 20615267
Drug: Fe plus
RxNorm normalized name: PureFe Plus
DrugBank: Zinc sulfate, unspecified form (DB14548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe plus 400 μg folic acid daily
Trial: 20615267
Drug: Fe plus
RxNorm normalized name: PureFe Plus
DrugBank: Zinc sulfate, unspecified form (DB14548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe plus 2 mg retinol and 1 mg riboflavin daily
Trial: 10469179
Drug: Recombinant FVIIa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant FVIIa (rFVIIa) treatment
Trial: 10469179
Drug: Recombinant FVIIa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant FVIIa (rFVIIa) treatment during surgery
Trial: 10469179
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events during treatment episodes
Trial: 7502551
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (bismuth subsalicylate, metronidazole, tetracycline plus ranitidine)
Trial: 7502551
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (omeprazole and amoxicillin)
Trial: 7502551
Drug: Cured H.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cured H. pylori infection (both therapies)
Trial: 2138684
Drug: Diclofenac +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac + vitamins B1 (50 mg), B6 (50 mg), B12 (0.25 mg)